4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-426810
Chief Legal Officer sold 1,635 shares at $12.84 ($20,993)
- Chief Legal Officer acquired 1,635 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bizily Scott · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,635 | $4.14 | $6,769 | 10,252 | D |
| 2026-10-16 | Sale : show line 2 in the form 10b5-1 | −1,635 | $12.84 | $20,993 | 8,617 | D |
| Open-market sales · 1,635 sh · avg $12.84 · $20,993 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-16 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −1,635 | 56,431 | D |
Loading xslF345X06/ownership.xml…